SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Mona Wagdy Ayad, Dalia Nafea, Acquired Mutation of the Tyrosine Kinase JAK2V617F in Egyptian Patients with Myeloid Disorders, Genetic Testing and Molecular Biomarkers, 2011, 15, 1-2, 17

    CrossRef

  2. 2
    Luke P. Akard, Y. Lynn Wang, Translating Trial-Based Molecular Monitoring Into Clinical Practice: Importance of International Standards and Practical Considerations for Community Practitioners, Clinical Lymphoma Myeloma and Leukemia, 2011, 11, 5, 385

    CrossRef

  3. 3
    Wing C. (John) Chan, Timothy C. Greiner, Adam Bagg, Hematopathology, 2011,

    CrossRef

  4. 4
    Sukru Palanduz, Aysegul Bayrak, Sema Sirma, Burcak Vural, Kivanc Cefle, Ali Ucur, Sukru Ozturk, Mustafa Nuri Yenerel, Sevgi K. Besisik, Selim Yavuz, Reyhan Diz-Kucukkaya, Deniz Sargin, Meliha Nalcaci, Yuksel Pekcelen, Ugur Ozbek, Comparison of the Cytogenetic and Molecular Analyses in the Assessment of Imatinib Response in Chronic Myelocytic Leukemia, Genetic Testing and Molecular Biomarkers, 2009, 13, 5, 599

    CrossRef

  5. 5
    Ayda Bennour, Halima Sennana, Mohamed Adnène Laatiri, Moez Elloumi, Abderrahim Khelif, Ali Saad, Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9, Cancer Genetics and Cytogenetics, 2009, 194, 1, 30

    CrossRef

  6. 6
    Hiromichi Matsushita, Atsuko Masukawa, Satoshi Arakawa, Yoshiaki Ogawa, Satomi Asai, Miharu Yabe, Kiyoshi Ando, Hayato Miyachi, Persistence of derivative chromosome 22 after achieving a major molecular response in chronic myeloid leukemia with a cryptic BCR-ABL1 fusion gene, International Journal of Hematology, 2009, 90, 5, 623

    CrossRef

  7. 7
    Michele Bianchini, Carlos De Brasi, Patricia Gargallo, Mariana Gonzalez, Raquel Bengió, Irene Larripa, Specific assessment of BCR–ABL transcript overexpression and imatinib resistance in chronic myeloid leukemia patients, European Journal of Haematology, 2009, 82, 4
  8. 8
    Hagop Kantarjian, Jorge Cortes, Abeloff's Clinical Oncology, 2008,

    CrossRef

  9. 9
    H. Kantarjian, C. Schiffer, D. Jones, J. Cortes, Monitoring the response and course of chronic myeloid leukemia in the modern era of BCR-ABL tyrosine kinase inhibitors: practical advice on the use and interpretation of monitoring methods, Blood, 2007, 111, 4, 1774

    CrossRef

  10. 10
    Yan Shi, Li-Zhen Li, Jian-Zhi Sun, Ti Zhang, Jun Peng, Cong-Gao Xu, Rapid detection of BCR-ABL fusion genes using a novel combined LUX primer, in-cell RT-PCR and flow cytometric method, Annals of Hematology, 2007, 87, 1, 35

    CrossRef

  11. 11
    Paul C. Park, Shamini Selvarajah, Jane Bayani, Maria Zielenska, Jeremy A. Squire, Stem cell enrichment approaches, Seminars in Cancer Biology, 2007, 17, 3, 257

    CrossRef

  12. 12
    Suneel Mundle, Yelina Noskina, Cytogenetic testing for therapeutic indication in cancer, Expert Review of Molecular Diagnostics, 2005, 5, 1, 23

    CrossRef

  13. 13
    Pia Raanani, Isaac Ben-Bassat, Shlomit Gan, Luba Trakhtenbrot, Ziva Mark, Osnat Ashur-Fabian, Svetlana Itskovich, Frida Brok-Simoni, Gideon Rechavi, Ninette Amariglio, Arnon Nagler, Assessment of the response to imatinib in chronic myeloid leukemia patients – comparison between the FISH, multiplex and RT-PCR methods, European Journal of Haematology, 2004, 73, 4
  14. 14
    Suneel D Mundle, Irina Sokolova, Clinical implications of advanced molecular cytogenetics in cancer, Expert Review of Molecular Diagnostics, 2004, 4, 1, 71

    CrossRef

  15. 15
    Dong Soon Lee, Encyclopedia of Medical Genomics and Proteomics, 2004,

    CrossRef

  16. 16
    Amgad L. Nashed, Kathleen W. Rao, Margaret L. Gulley, Clinical Applications of BCR-ABL Molecular Testing in Acute Leukemia, The Journal of Molecular Diagnostics, 2003, 5, 2, 63

    CrossRef

  17. 17
    Weng-Onn Lui, Trisha Dwight, Impact of molecular cytogenetics on localization and identification of cancer-related genes in endocrine tumor development, Current Opinion in Endocrinology and Diabetes, 2003, 10, 3, 176

    CrossRef

  18. 18
    Kathleen M. Duffy, Innovations in the Management of Leukemia, Cancer Nursing, 2003, 26, Supplement 6S, 26S???31S

    CrossRef

  19. 19
    Tim Hughes, Susan Branford, Molecular monitoring of chronic myeloid leukemia, Seminars in Hematology, 2003, 40, 62

    CrossRef

  20. 20
    Tim Hughes, Susan Branford, Molecular monitoring of chronic myeloid leukemia, Seminars in Hematology, 2003, 40, 2, 62

    CrossRef

  21. 21
    Oliver Bock, Dunja Reising, Hans Kreipe, Multiplex RT-PCR for the Detection of Common BCR-ABL Fusion Transcripts in Paraffin-Embedded Tissues From Patients With Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia, Diagnostic Molecular Pathology, 2003, 12, 3, 119

    CrossRef

  22. 22
    Adam Bagg, Chronic Myeloid Leukemia, The Journal of Molecular Diagnostics, 2002, 4, 1, 1

    CrossRef

  23. 23
    Dong Soon Lee, Yun-Song Lee, Young-Ree Kim, Kyu Sup Han, Kyoung Un Park, Cha Ja She, Eu Chong Kim, Sun Yang Park, Han Ik Cho, RARA fluorescence in situ hybridization overcomes the drawback of PML/RARA fluorescence in situ hybridization in follow-up of acute promyelocytic leukemia, Cancer Genetics and Cytogenetics, 2002, 139, 2, 104

    CrossRef